Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmaxim Holding AB
AB
Active
Org 5591339394
Stockholm
Activities of head offices
·
NACE 7010
Est. 2017 · 8 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Activities of head offices
/
Pharmaxim Holding AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
100
100
100
0
0
Staff expenses
—
—
—
—
—
EBITDA
−30
−386
−65
−4
−156
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−30
−386
−65
−4
−156
Net financials
−311
−49
−96
9 638
11 495
Profit before tax
3 153
24
6 920
9 634
11 338
Tax
−679
−24
−1 221
−0
−0
Net profit
2 474
0
5 699
9 634
11 338
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
88 434
86 300
84 844
79 105
77 690
Equity
57 974
55 821
56 123
50 424
40 790
Long-term debt
17 031
21 340
8 270
0
0
Short-term debt
8 585
5 394
6 706
16 911
25 131
Total debt
25 616
26 734
14 976
16 911
25 131
Financial ratios
5-year trend
EBITDA margin
−30,0 %
This company
15,8 %
Market median
This company
Market median
290% below market
2020
2024
Equity ratio
65,6 %
This company
38,2 %
Market median
This company
Market median
72% above market
2020
2024
Return on equity
4,3 %
This company
18,4 %
Market median
This company
Market median
77% below market
2020
2024
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
0,53×
This company
0,62×
Market median
This company
Market median
15% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Pharmaxim Holding AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot